Literature DB >> 3210285

Determinants of isolated systolic hypertension.

S V Wilking1, A Belanger, W B Kannel, R B D'Agostino, K Steel.   

Abstract

Isolated systolic hypertension (ISH), defined as systolic blood pressure of 160 mm Hg or greater when the diastolic pressure is less than 95 mm Hg, is a common form of hypertension among the elderly. We collected incidence and prevalence data on ISH and evaluated several potential factors for its occurrence in the Framingham Heart Study during 16 biennial examinations. The factors evaluated were age, sex, all components of the blood pressure (systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure), Metropolitan relative weight, serum cholesterol level, serum uric acid level, cigarette smoking, ventricular heart rate, glucose intolerance, and hematocrit. The population at risk (1687 men and 1992 women) were those members of the Framingham cohort with a systolic blood pressure less than 160 mm Hg in the first four biennial examinations. Results showed ISH in 14.4% of the men and 22.8% of the women. Cumulative incidence rates were 418 per 1000 in men and 533 per 1000 in women. Significant risk factors for ISH were age, sex, all components of the blood pressure, and increased relative weight in women. We conclude that ISH is a highly prevalent disorder. Its major determinants are age, sex, increasing levels of blood pressure, and obesity in women.

Entities:  

Mesh:

Year:  1988        PMID: 3210285

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  21 in total

Review 1.  What is the clinical relevance of isolated systolic hypertension?

Authors:  J P Emeriau
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

2.  Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance.

Authors: 
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

Review 3.  Optimal dosage of ACE inhibitors in older patients.

Authors:  B Tomlinson
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

4.  A comparison of amlodipine with enalapril in the treatment of isolated systolic hypertension.

Authors:  J Webster; G Fowler; T A Jeffers; D Lyons; K Witte; W A Crichton; E A Wickham; S S Sanghera; R Cornish; J C Petrie
Journal:  Br J Clin Pharmacol       Date:  1993-05       Impact factor: 4.335

Review 5.  Incentive spirometry for preventing pulmonary complications after coronary artery bypass graft.

Authors:  Eliane R F S Freitas; Bernardo G O Soares; Jefferson R Cardoso; Álvaro N Atallah
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

Review 6.  The changing face of hypertension and antihypertensive agents.

Authors:  M E Kitler
Journal:  Drugs Aging       Date:  1996-01       Impact factor: 3.923

Review 7.  Prevalence and implications of uncontrolled systolic hypertension.

Authors:  William B Kannel
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users.

Authors:  Alyce S Adams; Connie Uratsu; Wendy Dyer; David Magid; Patrick O'Connor; Arne Beck; Melissa Butler; P Michael Ho; Julie A Schmittdiel
Journal:  JAMA Intern Med       Date:  2013-01-14       Impact factor: 21.873

Review 9.  Mechanisms and management of stroke in the elderly.

Authors:  A Shuaib; V C Hachinski
Journal:  CMAJ       Date:  1991-09-01       Impact factor: 8.262

10.  Prevalence and determinants of isolated systolic hypertension among young adults: the 1999-2004 US National Health And Nutrition Examination Survey.

Authors:  Regina C Grebla; Carlos J Rodriguez; Luisa N Borrell; Thomas G Pickering
Journal:  J Hypertens       Date:  2010-01       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.